VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell.

Developing novel ways to refine, reduce and replace the use of animals in research and enhance animal and human health.